Company intelligence / Profile preview

Naturewohl Pharma

Gräfelfing, Bavaria, Germany

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Naturwohl Pharma is a German pharmaceutical company specializing in the development and marketing of over-the-counter (OTC) health products and dietary supplements. The company is most recognized for its flagship brand, Yokebe, a leading meal replacement product in the German weight-loss market. Naturwohl also pioneered the use of specific probiotic strains, notably Bifidobacterium bifidum MIMBb75, for the treatment of Irritable Bowel Syndrome (IBS). In 2015, the company was acquired by Perrigo Company plc for approximately $150 million, integrating its portfolio into Perrigo's European consumer healthcare business.

Therapeutic areas: EndocrinologyGastroenterology
Modalities: NutraceuticalProbioticDevice
Industry: Food & Nutrition

Beyond the preview

Go deeper on Naturewohl Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Naturewohl Pharma.

Explore the full profile